Myelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFusion Proteins, bcr-ablLeukemia, Myeloid, AcuteBlast CrisisLeukemia, MyeloidBenzamidesLeukemiaPiperazinesPyrimidinesPhiladelphia ChromosomeK562 CellsAnemia, Refractory, with Excess of BlastsAnemia, RefractoryLeukemia, Myeloid, Chronic-PhaseBone MarrowChromosomes, Human, 21-22 and YLeukemia, Myeloid, Accelerated PhaseGenes, ablLeukemia, Myelomonocytic, ChronicSyndromeKaryotypingLeukemia, Myeloid, Chronic, Atypical, BCR-ABL NegativeProto-Oncogene Proteins c-bcrCytarabineAntineoplastic AgentsBone Marrow TransplantationMyeloproliferative DisordersChromosome AberrationsHematopoietic Stem CellsCytogenetic AnalysisRemission InductionGene Expression Regulation, LeukemicChromosomes, Human, Pair 5AzacitidineTransplantation, HomologousAcute DiseaseHarringtoninesLeukemia, LymphoidCytogeneticsGranulocytesBone Marrow CellsTreatment OutcomeTranslocation, GeneticInterferon-alphaProtein-Tyrosine KinasesPrognosisPrecursor Cell Lymphoblastic Leukemia-LymphomaHematopoietic Stem Cell TransplantationAntigens, CD34Proto-Oncogene Proteins c-ablBusulfanDrug Resistance, NeoplasmGraft vs Host DiseaseNeoplastic Stem CellsPreleukemiaAnemia, SideroblasticMonosomySurvival AnalysisChromosomes, Human, Pair 7Leukemia, ExperimentalProtein Kinase InhibitorsTumor Cells, CulturedLeukemia, Lymphocytic, Chronic, B-CellDaunorubicinRNA, NeoplasmRecurrenceCore Binding Factor Alpha 2 SubunitApoptosisHematopoiesisIn Situ Hybridization, FluorescenceCell Transformation, NeoplasticAntineoplastic Combined Chemotherapy ProtocolsThrombocytosisHydroxyureaThalidomidePrimary MyelofibrosisAnemia, AplasticHL-60 CellsNeoplasm ProteinsSurvival RateChromosome DeletionChromosome DisordersMutationBlood Cell CountFlow CytometryTumor Stem Cell AssayMegakaryocytesChromosomes, Human, Pair 21Myelodysplastic-Myeloproliferative DiseasesPolymerase Chain ReactionPancytopeniaTransplantation ConditioningBase SequenceSialic Acid Binding Ig-like Lectin 3